Timrepigene emparvovec

DB16018InvestigationalGene Therapies

Timrepigene emparvovec: Overview.

Code names
AAV2-REP1 · BIIB-111 · NSR-REP1 · rAAV2-REP1 · WHO 10571

Resolves to

Compound
UNIIM9N48CJY6TCAS1905415-02-2

What you can answer from here — as of September 25, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Timrepigene emparvovec, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In